Join Jane Linderbaum MS, ARNP, FACC in this hypertrophic cardiomyopathy course. This presentation focuses first on identifying the signs, symptoms, and diagnostic criteria for hypertrophic cardiomyopathy, which can be challenging to diagnose, including the initial tests and diagnostic criteria that can be used to rule out other similar, conditions and diseases. Ms. Linderbaum goes on to describe the importance of shared decision-making with patients with HCM and discussed treatments, which range from medical therapy to surgery to help relieve patient symptoms and to prevent sudden cardiac disease.
Recorded on December 2, 2021, as part of the 2021 Heart Failure Summit.
Upon completion of this continuing education course, participants will be able to:
- Review the signs and symptoms of HCM, including diagnostic criteria
- Describe the clinical relationship between hypertrophic cardiomyopathy (HCM) and heart failure (HF)
- Discuss shared decision-making and treatment options for advanced HF in the HCM disease spectrum
- Jane A. Linderbaum MS, ARNP, FACC
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of PCNA. PCNA is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030602.